AtaiBeckley (ATAI) Times Interest Earned (2020 - 2026)
AtaiBeckley (ATAI) posted quarterly Times Interest Earned of -$0.52 for Q1 2026, up 97.69% year-over-year from -$0.26 in Q1 2025, and up 97.69% quarter-over-quarter from -$22.63 in Q1 2025.
AtaiBeckley (ATAI) Times Interest Earned (2020 - 2026) Analysis & Trends
AtaiBeckley has reported Times Interest Earned for 6 years, with the latest figure at -$0.24 in Q3 2025.
- Quarterly Times Interest Earned rose 96.43% year-over-year to -$0.24 in Q3 2025, while the trailing twelve-month figure through Sep 2025 was -$0.88 (up 97.21% YoY) and the FY2024 annual result came in at -$0.74, up 47.22% from the prior year.
- Times Interest Earned for Q1 2026 stood at -$0.52, up from -$22.63 in the prior quarter.
- The five-year high for Times Interest Earned was -$0.52 in Q1 2026, with the low at -$22.63 in Q1 2025.
- A 5-year average of $3.95 and a median of -$3.12 in 2023 frame the typical range for Times Interest Earned.
- The sharpest annual moves came in 2021 and 2023: Times Interest Earned sank 12532.24% in 2021, then jumped 2063.38% in 2023.
- Over 5 years, Times Interest Earned stood at -$0.15 in 2021, then sank by 26217.41% to -$40.7 in 2022, then jumped by 2063.38% to $799.07 in 2023, then tumbled by 97.73% to $18.1 in 2024, then tumbled by 101.32% to -$0.24 in 2025.
- According to Business Quant data, Times Interest Earned over the past three periods registered -$0.24, -$1.3, and -$22.63 for Q3 2025, Q2 2025, and Q1 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 2.84 |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 24.64 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -0.19 |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 8.18 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -0.01 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.61 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 2.82 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -0.08 |
| 10 | AtaiBeckley | 2.69 Bn | 2.69 Bn | - | -0.24 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.35 |
| Mar 31, 2026 | -0.52 |
| Sep 30, 2025 | -0.24 |
| Jun 30, 2025 | -1.30 |
| Mar 31, 2025 | -22.63 |
| Mar 31, 2025 | -22.63 |
| Dec 31, 2024 | 18.10 |
| Sep 30, 2024 | -6.71 |
| Jun 30, 2024 | -5.05 |
| Mar 31, 2024 | -35.06 |
| Dec 31, 2023 | 799.07 |
| Sep 30, 2023 | -5.59 |
| Jun 30, 2023 | -3.12 |
| Mar 31, 2023 | -53.40 |
| Dec 31, 2022 | -40.70 |
| Sep 30, 2022 | -2.35 |
| Mar 31, 2022 | -0.96 |
| Sep 30, 2021 | -0.15 |
| Jun 30, 2021 | -613.19 |
| Mar 31, 2021 | 40.50 |